share_log

Illumina | DEF 14A: Definitive information statements

Illumina | DEF 14A: Definitive information statements

Illumina | DEF 14A：股東委託書決議
美股SEC公告 ·  04/04 16:22

Moomoo AI 已提取核心訊息

Illumina, Inc., a global leader in DNA sequencing and array-based technologies, announced the filing of its definitive proxy statement with the SEC, scheduling its annual meeting of stockholders for May 16, 2024. The meeting, to be held virtually, will allow stockholders to elect eleven board nominees, ratify the appointment of Ernst & Young LLP as the independent auditor for the fiscal year ending December 29, 2024, and vote on an advisory resolution to approve executive compensation. The Board unanimously recommends voting for all proposals. Stockholders as of the record date, March 22, 2024, are entitled to vote. The proxy materials are available at www.proxyvote.com, and stockholders can vote via the internet, telephone, or mail prior to the meeting. The Board also addressed the anticipated divestiture of GRAIL, aiming to finalize terms by the second quarter of 2024. The proxy statement includes compensation details for named executive officers, with CEO Jacob Thaysen's compensation package reflecting stockholder feedback on performance alignment.
Illumina, Inc., a global leader in DNA sequencing and array-based technologies, announced the filing of its definitive proxy statement with the SEC, scheduling its annual meeting of stockholders for May 16, 2024. The meeting, to be held virtually, will allow stockholders to elect eleven board nominees, ratify the appointment of Ernst & Young LLP as the independent auditor for the fiscal year ending December 29, 2024, and vote on an advisory resolution to approve executive compensation. The Board unanimously recommends voting for all proposals. Stockholders as of the record date, March 22, 2024, are entitled to vote. The proxy materials are available at www.proxyvote.com, and stockholders can vote via the internet, telephone, or mail prior to the meeting. The Board also addressed the anticipated divestiture of GRAIL, aiming to finalize terms by the second quarter of 2024. The proxy statement includes compensation details for named executive officers, with CEO Jacob Thaysen's compensation package reflecting stockholder feedback on performance alignment.
DNA測序和基於陣列的技術領域的全球領導者Illumina, Inc. 宣佈向美國證券交易委員會提交其最終委託書，並計劃於2024年5月16日舉行年度股東大會。該會議將以虛擬方式舉行，將允許股東選出11名董事會候選人，批准任命安永會計師事務所爲截至2024年12月29日的財政年度的獨立核數師，並對批准高管薪酬的諮詢決議進行投票。董事會一致建議對所有提案進行投票。截至創紀錄的日期，即2024年3月22日，股東有權投票。代理材料可在www.proxyvote.com上獲得，股東可以在會議之前通過互聯網、電話或郵件進行投票。董事會還討論了GRAIL的預期剝離，目標是在2024年第二季度之前敲定條款。委託書包括指定執行官的薪酬細節，首席執行官雅各布·塞森的薪酬待遇反映了股東對業績調整的反饋。
DNA測序和基於陣列的技術領域的全球領導者Illumina, Inc. 宣佈向美國證券交易委員會提交其最終委託書，並計劃於2024年5月16日舉行年度股東大會。該會議將以虛擬方式舉行，將允許股東選出11名董事會候選人，批准任命安永會計師事務所爲截至2024年12月29日的財政年度的獨立核數師，並對批准高管薪酬的諮詢決議進行投票。董事會一致建議對所有提案進行投票。截至創紀錄的日期，即2024年3月22日，股東有權投票。代理材料可在www.proxyvote.com上獲得，股東可以在會議之前通過互聯網、電話或郵件進行投票。董事會還討論了GRAIL的預期剝離，目標是在2024年第二季度之前敲定條款。委託書包括指定執行官的薪酬細節，首席執行官雅各布·塞森的薪酬待遇反映了股東對業績調整的反饋。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    熱議
    美股
    股票代碼最新價升跌幅

    暫無數據

    資訊熱榜
    更新時間